MLV & Co. Downgrades Uroplasty (UPI) to Hold - InvestingChannel

MLV & Co. Downgrades Uroplasty (UPI) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

Top NewsMost Read Highlighted

Get AlertsUPI Hot Sheet

Rating Summary:

3 Buy, 2 Hold, 0 Sell

Rating Trend: Down

Today’s Overall Ratings:

MLV & Co. downgraded Uroplasty (NASDAQ: UPI) from Buy to Hold with a price target of $3.00.

For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.

Shares of Uroplasty closed at $2.74 yesterday, with a 52 week range of $2.58-$4.78.

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW